VRAX (Virax Biolabs Group) Change In Inventory : $-0.03 Mil (TTM As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Virax Biolabs Group Change In Inventory?

Virax Biolabs Group's change in inventory for the quarter that ended in Mar. 2025 was $0.03 Mil. It means Virax Biolabs Group's inventory declined by $0.03 Mil from Sep. 2024 to Mar. 2025 .

Virax Biolabs Group's change in inventory for the fiscal year that ended in Mar. 2025 was $-0.03 Mil. It means Virax Biolabs Group's inventory increased by $0.03 Mil from Mar. 2024 to Mar. 2025 .

Virax Biolabs Group's Total Inventories for the quarter that ended in Mar. 2025 was $0.10 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Virax Biolabs Group's Days Inventory for the quarter that ended in Mar. 2025 was 418.23.

Inventory Turnover measures how fast the company turns over its inventory within a year. Virax Biolabs Group's Inventory Turnover for the quarter that ended in Mar. 2025 was 0.44.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Virax Biolabs Group's Inventory-to-Revenue for the quarter that ended in Mar. 2025 was 110.00.

Virax Biolabs Group Change In Inventory Historical Data

The historical data trend for Virax Biolabs Group's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virax Biolabs Group Change In Inventory Chart

Virax Biolabs Group Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Change In Inventory

Get a 7-Day Free Trial

-0.02

0.02

-0.06

-0.03

Virax Biolabs Group Semi-Annual Data
	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24	Mar25
Change In Inventory	Get a 7-Day Free Trial						-	-0.03	-0.04	-0.07	0.03

Virax Biolabs Group Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.03 Mil.

Virax Biolabs Group (NAS:VRAX) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Virax Biolabs Group's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0.11	/	0.048	*	365 / 2
	=	418.23

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Virax Biolabs Group's Inventory Turnover for the quarter that ended in Mar. 2025 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.048	/	0.11
	=	0.44

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Virax Biolabs Group's Inventory to Revenue for the quarter that ended in Mar. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.11	/	0.001
	=	110.00

Virax Biolabs Group Change In Inventory Related Terms

Thank you for viewing the detailed overview of Virax Biolabs Group's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Virax Biolabs Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Virax Biolabs Group Ltd (NAS:VRAX) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bo’Ness Road Newhouse, BioCity Glasgow, London, GBR, ML1 5UH

Website

https://www.viraxbiolabs.com

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.